Background We aimed to ascertain the cumulative risk of fatal or critical care unit-treated
COVID-19 in people with diabetes and compare it with that of people without diabetes, and to …

Background Although diabetic kidney disease demonstrates both familial clustering and
single nucleotide polymorphism heritability, the specific genetic factors influencing risk remain …

Effector functions of immunoglobulin G (IgG) are regulated by the composition of a glycan
moiety, thus affecting activity of the immune system. Aberrant glycosylation of IgG has been …

OBJECTIVE Poorer glycemic control in type 1 diabetes may alter N-glycosylation patterns on
circulating glycoproteins, and these alterations may be linked with diabetic kidney disease (…

Background The objectives of this study were to identify risk factors for severe coronavirus
disease 2019 (COVID-19) and to lay the basis for risk stratification based on demographic …

Background The objective of this study was to investigate the relation of severe COVID-19 to
prior drug prescribing. Methods Severe cases were defined by entry to critical care or fatal …

Aims/hypothesis We assessed the real-world effect of flash monitor (FM) usage on HbA 1c
levels and diabetic ketoacidosis (DKA) and severe hospitalised hypoglycaemia (SHH) rates …

Aims/hypothesis We aimed to report current rates of CVD in type 1 diabetes and to develop
a CVD risk prediction tool for type 1 diabetes. Methods A cohort of 27,527 people with type 1 …

Aims/hypothesis Dapagliflozin, a sodium–glucose cotransporter 2 (SGLT2) inhibitor, is
indicated for improving glycaemic control in type 2 diabetes mellitus. Whether its effects on HbA …

Aims/hypothesis We examined whether candidate biomarkers in serum or urine can
improve the prediction of renal disease progression in type 1 diabetes beyond prior eGFR, …